Integrated Filing — IndAS



General information about company

Scrip Code 544311
NSE Symbol IGIL
MSEI Symbol NOTLISTED
ISIN INE0Q9301021
Name of company International Gemmological Institute (India) Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Jan-2025
Date of end of financial year 31-Dec-2025
Date of board meeting when results were approved 29-Jul-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-Jul-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Certification of Diamonds, gemstones, jewellery and related education.
Start date and time of board meeting 29-Jul-2025   14:30:00
End date and time of board meeting 29-Jul-2025   16:05:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? No
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-08-02
Indicate Company website link for updated RPT policy of the Company www.igi.org
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025 01-Jan-2025
B Date of end of reporting period 30-Jun-2025 30-Jun-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 2341300000 4683310000
Other income 145110000 246970000
Total income 2486410000 4930280000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 2320000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -10660000 -8280000
(d) Employee benefit expense 305890000 579150000
(e) Finance costs 5400000 10960000
(f) Depreciation, depletion and amortisation expense 41240000 79680000
(f) Other Expenses
1 Other Expenses 336660000 582210000
Total other expenses 336660000 582210000
Total expenses 678530000 1246040000
3 Total profit before exceptional items and tax 1807880000 3684240000
4 Exceptional items 0 0
5 Total profit before tax 1807880000 3684240000
6 Tax expense
7 Current tax 418560000 904210000
8 Deferred tax 14520000 13800000
9 Total tax expenses 433080000 918010000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 1374800000 2766230000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 1374800000 2766230000
17 Other comprehensive income net of taxes -3340000 -6740000
18 Total Comprehensive Income for the period 1371460000 2759490000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 864320000 864320000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.18 6.4
Diluted earnings (loss) per share from continuing operations 3.06 6.15
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.18 6.4
Diluted earnings (loss) per share from continuing and discontinued operations 3.06 6.15
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) For notes please refer Financial Results uploaded on Stock Exchange and Website of the Company



Remarks

Debt equity ratio There is no debt in the company and hence Not applicable
Debt service coverage ratio There is no debt in the company and hence Not applicable
Interest service coverage ratio There is no debt in the company and hence Not applicable


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025
Date of end of reporting period 30-Jun-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1176190000
Capital work-in-progress 450490000
Investment property
Goodwill 0
Other intangible assets 40670000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 13491270000
Trade receivables, non-current
Loans, non-current 0
Other non-current financial assets 808920000
Total non-current financial assets 14300190000
Deferred tax assets (net) 104340000
Other non-current assets 148360000
Total non-current assets 16220240000
2 Current assets
Inventories 14780000
Current financial asset
Current investments 0
Trade receivables, current 1896660000
Cash and cash equivalents 126820000
Bank balance other than cash and cash equivalents 563710000
Loans, current 68300000
Other current financial assets 6079640000
Total current financial assets 8735130000
Current tax assets (net)
Other current assets 83180000
Total current assets 8833090000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 25053330000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 864320000
Other equity 22725370000
Total equity attributable to owners of parent 23589690000
Non controlling interest
Total equity 23589690000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 286440000
Total non-current financial liabilities 286440000
Provisions, non-current 0
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 286440000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 26430000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 208070000
Total Trade payable 234500000
Other current financial liabilities 556680000
Total current financial liabilities 791180000
Other current liabilities 386020000
Provisions, current 0
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 1177200000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1463640000
Total equity and liabilites 25053330000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025 01-Jan-2025
Date of end of reporting period 30-Jun-2025 30-Jun-2025
Whether accounts are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025 01-Jan-2025
B Date of end of reporting period 30-Jun-2025 30-Jun-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of actuarial gain/(loss) -4460000 -9000000
Total Amount of items that will not be reclassified to profit and loss -4460000 -9000000
2 Income tax relating to items that will not be reclassified to profit or loss -1120000 -2260000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -3340000 -6740000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 3684240000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 10960000
Adjustments for decrease (increase) in inventories -8280000
Adjustments for decrease (increase) in trade receivables, current -427790000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 3910000
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 1632220000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -244280000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 24350000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 79680000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current -934420000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 4370000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 140720000
Net cash flows from (used in) operations 3824960000
Dividends received 0
Interest paid 0
Interest received -210030000
Income taxes paid (refund) 1050000000
Other inflows (outflows) of cash -13610000
Net cash flows from (used in) operating activities 2551320000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 2410000
Purchase of property, plant and equipment 222660000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 202350000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -1982400000
Net cash flows from (used in) investing activities -2000300000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Payments of lease liabilities 48510000
Dividends paid 1054300000
Interest paid 10960000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -1113770000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -562750000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -562750000
Cash and cash equivalents cash flow statement at beginning of period 689570000
Cash and cash equivalents cash flow statement at end of period 126820000





Details of Impact of Audit Qualification

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates Yes 31-Jul-2027


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 International Gemmological Institute (India) Limited IGI (Shanghai) Gemological Research and Testing Limited Indirect Subsidiary Purchase of goods or services 10000000 Approved 620000 0 0
2 International Gemmological Institute (India) Limited IGI (Shanghai) Gemological Research and Testing Ltd. Indirect Subsidiary Sale of goods or services 20000000 Approved 5660000 0 0
3 International Gemmological Institute (India) Limited IGI (Shenzhen) Jewelry Testing Ltd. Indirect Subsidiary Sale of goods or services 20000000 Approved 3370000 3000000 6520000
4 International Gemmological Institute (India) Limited IGI Netherlands B.V. Direct Subsidiary Any other transaction Payment against expenses 10000000 Approved 1060000 0 1070000
5 International Gemmological Institute (India) Limited IGI(Shanghai) Gemological Training Company Limited. Indirect Subsidiary Purchase of goods or services 10000000 Approved 30000 0 0
6 International Gemmological Institute (India) Limited IGI(Shanghai) Gemological Training Company Limited. Indirect Subsidiary Any other transaction Reimbursement of expenses 10000000 Approved 260000 0 260000
7 International Gemmological Institute (India) Limited International Gemmological Identification (Thailand) Limited Indirect Subsidiary Sale of goods or services 10000000 Approved 590000 1000000 2060000
8 International Gemmological Institute (India) Limited International Gemmological Identification (Thailand) Limited Indirect Subsidiary Any other transaction Reimbursement of expenses 10000000 Approved 50000 1000000 0
9 International Gemmological Institute (India) Limited International Gemmological Institute (Israel) Ltd. Indirect Subsidiary Sale of goods or services 20000000 Approved 7570000 0 7640000
10 International Gemmological Institute (India) Limited International Gemmological Institute BV Direct Subsidiary Any other transaction Payment against various expenses 10000000 Approved 1370000 2000000 0
11 International Gemmological Institute (India) Limited International Gemmological Institute BV Direct Subsidiary Purchase of goods or services 10000000 Approved 510000 0 3060000
12 International Gemmological Institute (India) Limited International Gemmological Institute BV Direct Subsidiary Sale of goods or services 10000000 Approved 1280000 2000000 3110000
13 International Gemmological Institute (India) Limited International Gemmological Institute FZCO Indirect Subsidiary Sale of goods or services 20000000 Approved 4250000 0 4910000
14 International Gemmological Institute (India) Limited International Gemmological Institute FZCO Indirect Subsidiary Any other transaction Reimbursement of expenses 10000000 Approved 980000 0 0
15 International Gemmological Institute (India) Limited International Gemmological Institute Inc. Indirect Subsidiary Any other transaction Payment against various expenses 1000000000 Approved 2300000 14000000 0
16 International Gemmological Institute (India) Limited International Gemmological Institute Inc. Indirect Subsidiary Any other transaction Commission income 500000000 Approved 1330000 14000000 3630000
17 International Gemmological Institute (India) Limited International Gemmological Institute Inc. Indirect Subsidiary Any other transaction Commission expense 1000000000 Approved 28870000 40000000 14750000
18 International Gemmological Institute (India) Limited International Gemmological Institute Inc. Indirect Subsidiary Sale of goods or services 500000000 Approved 290000 40000000 0
19 International Gemmological Institute (India) Limited International Gemmological Institute Inc. Indirect Subsidiary Any other transaction Reimbursement of expenses 10000000 Approved 640000 14000000 0
20 International Gemmological Institute (India) Limited International Gemmological Institute Turkey Precious Stone Certification Services Joint Stock Company Direct Subsidiary Sale of goods or services 10000000 Approved 890000 4000000 5410000
21 International Gemmological Institute (India) Limited International Gemmological Institute Turkey Precious Stone Certification Services Joint Stock Company Direct Subsidiary Any other transaction Interest from subsidiary 10000000 Approved 3680000 76000000 0
22 International Gemmological Institute (India) Limited International Gemmological Institute Turkey Precious Stone Certification Services Joint Stock Company Direct Subsidiary Any other transaction Reimbursement of expenses 10000000 Approved 320000 0 0
23 International Gemmological Institute (India) Limited International Gemological Institute (HK) Limited Indirect Subsidiary Purchase of goods or services 10000000 Approved 40000 0 350000
24 International Gemmological Institute (India) Limited International Gemological Institute (HK) Limited Indirect Subsidiary Sale of goods or services 10000000 Approved 760000 1000000 1450000
25 International Gemmological Institute (India) Limited International Gemological Institute FZCO Indirect Subsidiary Any other transaction Commission expense 30000000 Approved 14640000 0 15310000
26 International Gemmological Institute (India) Limited BCP Asia ll Topco Pte. Ltd. Holding Company Dividend paid Not Applicable 807240000 0 0
Total value of transaction during the reporting period 888600000